The long-term objective of this proposal is to understand the mechanisms by which mediators of the innate immune system induce antigen-nonspecific protection from infectious pathogens and contribute to pathogenesis of disease caused by agents of bioterrorism. Toll-like receptors (TLR) play a critical role in innate immunity by recognizing constitutive and conserved microbial components termed pathogen-associated molecular patterns (PAMPs). Recent evidence suggests that the TLRs can differentially activate innate effector functions, such as type I interferon (IFNalpha/beta), leading to increasing interest in use of synthetic innate immune activators as a novel therapeutic strategy against infection. However, TLRs are also thought contribute to disease pathogenesis of some types of bioterrorism agents by inducing inflammation, immune injury, ultimately resulting in toxic effects on the host. The mechanisms by which TLR-specific signal transduction and gene expression occur are poorly understood. In addition, pathogens may have developed strategies to avoid being eliminated through inhibiting TLR-mediated signal transduction pathways. Over the last three years, we have developed a system to study the signaling, gene expression and functional specificity among the TLRs. Our recent results indicate that certain TLRs (such as TLR9) utilize the p38-dependentsignal transduction pathways to preferentially activate phagocytosis and inflammatory responses. Other TLRs(such as TLR3), use the IRF3 pathway to induce type I interferons and non-specific viral resistance. In the current proposal, we will focus our efforts on understanding the biochemical mechanisms by which the TLRs specifically activate signal transduction pathways to induce innate biodefense. We will determine the mechanisms responsible for TLR-mediated signal specificity at the levels of membrane receptors, cytoplasmic signaling complexes and nuclear transcription factors. Through these studies, we hope to identify potential cellular targets that can separate TLR-mediated antiviral response from TLR-mediated inflammatory response. In order to apply the knowledge we might gain about mechanisms governing TLR-specific immune responses to possible clinical scenarios, we will develop an antiviral model in mice by administering purified or synthetic TLR agonists to determine their effects in the treatment of mice infected with viruses such as influenza. We believe our studies will not only help us to understand the molecular mechanisms responsible for TLR specificity in normal immune responses, but will also provide insightful for design of future therapeutic agents that enhance innate immunity in host biodefense against infectious pathogens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI056154-01A1
Application #
6776565
Study Section
Special Emphasis Panel (ZRG1-SSS-F (01))
Program Officer
Winter, David B
Project Start
2004-02-15
Project End
2009-01-31
Budget Start
2004-02-15
Budget End
2005-01-31
Support Year
1
Fiscal Year
2004
Total Cost
$376,492
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Foo, Suan-Sin; Chen, Weiqiang; Chan, Yen et al. (2018) Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight 3:
Zhu, Xingliang; Li, Chunfeng; Afridi, Shabbir Khan et al. (2018) E90 subunit vaccine protects mice from Zika virus infection and microcephaly. Acta Neuropathol Commun 6:77
Parvatiyar, Kislay; Pindado, Jose; Dev, Anurupa et al. (2018) A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling. Nat Commun 9:2770
Li, Chunfeng; Deng, Yong-Qiang; Wang, Shuo et al. (2017) 25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model. Immunity 46:446-456
Watanabe, Momoko; Buth, Jessie E; Vishlaghi, Neda et al. (2017) Self-Organized Cerebral Organoids with Human-Specific Features Predict Effective Drugs to Combat Zika Virus Infection. Cell Rep 21:517-532
Quanquin, Natalie; Wang, Lulan; Cheng, Genhong (2017) Potential for treatment and a Zika virus vaccine. Curr Opin Pediatr 29:114-121
Li, Chunfeng; Zhu, Xingliang; Ji, Xue et al. (2017) Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice. EBioMedicine 24:189-194
Wang, Lulan; Liu, Su-Yang; Chen, Hsiang-Wen et al. (2017) Generation of a Live Attenuated Influenza Vaccine that Elicits Broad Protection in Mice and Ferrets. Cell Host Microbe 21:334-343
Wang, Lulan; Valderramos, Stephanie G; Wu, Aiping et al. (2016) From Mosquitos to Humans: Genetic Evolution of Zika Virus. Cell Host Microbe 19:561-5
Boxx, Gayle M; Cheng, Genhong (2016) The Roles of Type I Interferon in Bacterial Infection. Cell Host Microbe 19:760-9

Showing the most recent 10 out of 58 publications